KPV

FDA APPROVAL PENDING

KPV

Anti-Inflammatory Tripeptide | Alpha-MSH Fragment

Learn more

Healing

KPV

Immunity

0

Amino acids

0da

Molecular weight

Peptide

Type

KPV is a potent anti-inflammatory tripeptide derived from the C-terminal of alpha-MSH. It exhibits remarkable anti-inflammatory and antimicrobial properties without the pigmentation effects of full α-MSH, making it ideal for inflammation management.

Top researched benefits

Overview of KPV

Enters cells and inhibits inflammatory pathways at the nuclear level, particularly NF-κB signaling. Reduces pro-inflammatory cytokines (TNF-α, IL-6) without causing immunosuppression like steroids.

inflammation

  • Reduces TNF-α and IL-6 through NF-κB pathway inhibition.
  • May help balance overactive immune responses in autoimmune conditions.
  • Potential benefits for inflammatory arthritis through cytokine reduction.

gut health

  • Demonstrated benefit in Crohn's disease and ulcerative colitis models.
  • Helps restore intestinal barrier function.
  • Selective antimicrobial activity preserves beneficial gut bacteria.

skin health

  • Topical KPV reduced psoriatic markers by 60% and improved skin barrier function.
  • Reduces inflammatory skin conditions without systemic effects.

Typical Dose

200-500 mcg per injection

Frequency

1-2 times daily (once for maintenance, twice for active inflammation)

Cycle Duration

4-8 weeks

Storage

Lyophilized: Room temperature. Reconstituted: 2-8°C, refrigerate immediately

No visual available

Due to this peptide having no amino acids, there is no molecular chain to display.

Chemical Makeup

Key benefits

Systemic anti-inflammatory effects

No pigmentation/tanning effects

Immune modulation without immunosuppression

Potential for autoimmune conditions

Gut health support

Multiple delivery routes available

Community interest

This peptide is still gaining traction in the community.

Anti-Inflammatory Tripeptide | Alpha-MSH Fragment

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes
No

KPV Protocols

Subcutaneous injection provides systemic anti-inflammatory effects. Abdomen is preferred for gut-related issues.

GoalDosageFrequencyRoute
General anti-inflammatory2001 week rangeSubQ
Active inflammation2502 week rangeSubQ
Autoimmune support5001 week rangeSubQ
Acute flare-ups5002 week rangeSubQ

Reconstitution Instructions

Materials needed:

KPV lyophilized powderBacteriostatic waterInsulin syringesAlcohol swabs

Steps to reconstitute

  1. Clean vial with alcohol pad
  2. Add 1mL bacteriostatic water to 1mg vial (1000mcg/mL)
  3. Or add 2mL for 500mcg/mL concentration
  4. Gently swirl - dissolves easily
  5. Solution should be clear and colorless
  6. Label with concentration and date
  7. Refrigerate immediately

KPV Cycle

The KPV Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Day 1-3
Subtle reduction in inflammation, improved energy
Week 0-0
Noticeable decrease in inflammatory symptoms
Week 2-3
Improved gut function (if applicable), reduced pain/swelling
Week 0-0
Significant improvement in inflammatory markers
Week 6-8
Sustained benefits, improved quality of life

Dosing tools

KPV Peptide Dosage Calculator

Calculate peptide doses with our visual syringe guide.

mg

Enter the total amount of peptide in the vial in milligrams (as stated on the label).

The dose you want to inject per administration, in mcg or mg.

1,000 mcg = 1 mg

1 mL

2 mL

3 mL

5 mL

Custom

Volume of bacteriostatic water you add to reconstitute the powder. Use BAC water for preservation.

Injection Results

Based on your vial and dilution inputs.

KPV

SINGLE COMPOUND

Volume per injection

0.05

mL

Concentration

10.00

mg/mL

Doses per vial

20

doses

Total injections per vial

20 injections

How it works

Based on a 10 mg KPV vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.

1mL / 100 units

5 units

0.050 mL

Reference Guide

Dosing Cycle

Peptide
KPV
Dosing
200-500 mcg per injection
Dosing Frequency
1-2 times daily (once for maintenance, twice for active inflammation)
Cycle Duration
4-8 weeks
Storage
Lyophilized: Room temperature. Reconstituted: 2-8°C, refrigerate immediately

Note: Triple agonist; microdose for fewer side effects

Reconstitution Tips

  • Use bacteriostatic water (BAC)contains 0.9% benzyl alcohol for preservation
  • Inject water slowlyaim down the vial wall, not directly onto powder
  • Never shakegently swirl or roll the vial until dissolved
  • Store properlyrefrigerate at 2-8°C after reconstitution
  • Use within 28 daysmost reconstituted peptides remain stable for about 4 weeks
  • Keep sterilealways clean vial tops with alcohol before drawing

Peptide Interactions

Research suggestions of KPV interactions with other common peptides and substances.

Healing

bpc

Longevity

BPC-157

SYNERGISTIC

Enhanced gut healing and anti-inflammatory effects through complementary mechanisms.

SYNERGISTIC

Healing

ghk

Longevity

GHK-Cu

SYNERGISTIC

Synergistic for skin health and regeneration.

SYNERGISTIC

Healing

ll3

Immunity

LL-37

SYNERGISTIC

Complementary antimicrobial and healing effects.

SYNERGISTIC

Skin

mela

Sexual

Melanotan II

MONITOR

Both are α-MSH related; KPV lacks pigmentation effects but monitor for cumulative effects.

MONITOR

Healing

tb5

Longevity

TB-500

COMPATIBLE

Different mechanisms; can be combined safely.

COMPATIBLE

Side effects

Monitor: Be careful when combining KPV with Melanotan II.

Contraindications

Known peptide allergies

Active severe infections (theoretical)

Pregnancy or breastfeeding (limited data)

Stop signs

Signs of infection (fever, chills) - very rare

Severe injection site reactions

Paradoxical inflammation increase

Allergic reaction symptoms

Unusual fatigue or weakness

Bad signs

Visible particles indicate contamination/degradationYellow coloration indicates oxidation/potency loss
Was it helpful?Yes
No

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What is a peptide dosage calculator?

A peptide dosage calculator is a free tool that converts your vial size, bacteriostatic water volume, and target dose into an exact syringe draw volume. Instead of doing the reconstitution math by hand, you enter three inputs and instantly get the concentration of your solution and how many milliliters or syringeunits to draw. This calculator works for single peptide compounds and multi-peptide blends.

How do I calculate peptide dosage from a vial?

To calculate your peptide dose, divide the total peptide content of your vial in micrograms by the volume of bacteriostatic water you added in milliliters. This gives you your solution concentration in mcg/mL. Then divide your target dose by that concentration to get your draw volume. For example, a 5mg (5,000 mcg) vial reconstituted with 2mL of BAC water gives a concentration of 2,500 mcg/mL. A 250 mcg dose would require drawing 0.1mL. This calculator automates all of those steps instantly.

How much Bacteriostatic water should I add to a peptide vial?

Most people add 2mL to 3mL of bacteriostatic water per vial, but the right amount depends on the dose you want to draw and the syringe size you are using. Adding 1mL to a 5mg vial gives you a concentration of 5,000 mcg/mL, making each dose very small in volume. Adding 2mL gives you 2,500 mcg/mL, which is easier to measure on a standard insulin syringe. A general guideline is to choose a volume that puts your typical dose somewhere between 10 and 30 units on a U-100 syringe. Use the calculator above to test different water volumes and find what works for your dose.

How are peptides different from proteins?

Both are made of amino acids, but peptides are much smaller than proteins. Because of their tiny size, peptides can act like tiny messengers in the body, sending specific signals to your cells to tell them exactly what to do.​

KPVResearch References

KPV is an emerging compound

4Research references

KPV

KPV is an emerging compound

KPV in IBD Models

Demonstrated significant reduction in inflammatory markers and improved intestinal barrier function in IBD models.

2019

Anti-Inflammatory Mechanisms Study

KPV enters cells and directly inhibits NF-κB pathway, reducing TNF-α, IL-6, and other inflammatory cytokines.

2020

Psoriasis/Dermatitis Study

Topical KPV reduced psoriatic markers by 60% and improved skin barrier function.

2021

Antimicrobial Properties Study

Showed selective antimicrobial activity against pathogenic bacteria while preserving beneficial gut microbiota.

2022